Geode Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $8.22 Million - $9.61 Million	83,026 Added 2.53%	3,360,567 $389 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $9.49 Million - $11.1 Million	98,488 Added 3.1%	3,277,541 $337 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $11.3 Million - $11.9 Million	105,252 Added 3.42%	3,179,053 $347 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $3.4 Million - $6.2 Million	54,463 Added 1.8%	3,073,801 $349 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $1.41 Million - $2.03 Million	23,963 Added 0.8%	3,019,338 $187 Million

Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $1.38 Million - $2.02 Million	-17,320 Reduced 0.57%	2,995,375 $239 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $9.28 Million - $11.8 Million	107,397 Added 3.7%	3,012,695 $317 Million
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $8.94 Million - $10.9 Million	90,703 Added 3.22%	2,905,298 $313 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $551 - $662	6 Added 0.0%	2,814,595 $308 Million
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $9.45 Million - $10.5 Million	109,550 Added 4.05%	2,814,589 $263 Million
Q1 2021 May 12, 2021	BUY	$71.83 - $95.48 $6.42 Million - $8.54 Million	89,414 Added 3.42%	2,705,039 $249 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $18 Million - $22.7 Million	269,175 Added 11.47%	2,615,625 $191 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $6.47 Million - $9.36 Million	117,135 Added 5.25%	2,346,450 $182 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $461,576 - $870,882	15,284 Added 0.69%	2,229,315 $124 Million
Q1 2020 May 14, 2020	BUY	$24.87 - $38.56 $2.27 Million - $3.52 Million	91,168 Added 4.29%	2,214,031 $65.6 Million
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $1.67 Million - $2.41 Million	65,694 Added 3.19%	2,122,863 $76.8 Million
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $426,535 - $518,703	-18,545 Reduced 0.89%	2,057,169 $56 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $47.3 Million - $59.1 Million	2,075,714 New	2,075,714 $49.9 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account